高压氧结合激素治疗痛性眼肌麻痹综合征的临床实效性  

Clinical effectiveness of hyperbaric oxygen combined with hormone treatment on painful ophthalmoplegia syndrome

作　　者：丁姝月[1] 秦娜[1] 王芳英[1] 

机构地区：[1]内蒙古巴彦淖尔市医院神经内三科,内蒙古巴彦淖尔015000

出　　处：《四川生理科学杂志》2016年第4期209-211,共3页Sichuan Journal of Physiological Sciences

摘　　要：目的：探讨和分析高压氧结合激素治疗痛性眼肌麻痹综合征的临床效果及其应用推广价值。方法：采取回顾分析的方法,从我院近三年（2012年3月-2015年3月）收治的痛性眼肌麻痹综合征患者中随机选取22例,入选的22例痛性眼肌麻痹综合征患者分为两组：对照组采用常规激素治疗（n=11）,观察组在原有常规激素治疗基础上结合高压氧配合治疗（n=11）。治疗2-3个疗程后,统计比较两组患者临床治疗效果。结果：在临床实效性对比上,观察组治愈率100%,优于对照组（治愈率81.8%）,差异有统计学意义（P〈0.05）。结论：高压氧结合激素治疗痛性眼肌麻痹综合征,对于改善患者的预后不良情况,提高临床治愈率,降低复发率,具有极高的应用价值,值得推广。Objective：To discuss and analyze the clinical effect and application value of hyperbaric oxygen combined hormone therapy on painful ophthalmoplegia syndrome.Methods：A retrospective analysis of 22 cases of painful ophthalmoplegia syndrome in our hospital（March 2012-March 2015）.All patients were randomly divided into two groups,11 cases with conventional hormone therapy（control group）,and 11 cases in the original combination of hyperbaric oxygen therapy on the basis of conventional hormone therapy with（study group）.After treatment（2-3courses）,the clinical effect of the two groups were compared.Results：Comparative clinical effectiveness in the observation group（100% cure rate）than the control group（81.8% cure rate）,the difference was statistically significant（P〈0.05）.Conclusion：Hyperbaric oxygen combined hormone therapy painful ophthalmoplegia syndrome,to improve the patient′s poor prognosis cases,improve the clinical cure rate and reduce the recurrence rate,has a very high value,worthy of promotion.

关 键 词：高压氧 激素 痛性眼肌麻痹综合征 

分 类 号：R777.45[医药卫生—眼科]